Literature DB >> 28742384

Antiproliferative Effects of Red and White Wine Extracts in PC-3 Prostate Cancer Cells.

Roxane Tenta1, Elizabeth Fragopoulou1, Magafoula Tsoukala1, Marianna Xanthopoulou1, Maria Skyrianou1, Harris Pratsinis2, Dimitris Kletsas2.   

Abstract

Experimental and epidemiological studies have shown that antioxidant polyphenols can act as chemopreventive agents against prostate cancer. Cabernet Sauvignon and Rombola wine were extracted in order to obtain fractions containing different classes of compounds. All extracts inhibited the androgen-insensitive human prostate cancer cells (PC-3) proliferation in a dose-dependent manner. The most potent compounds were selected to be further tested.Treatment of PC-3 cells with the selected wine extracts marginally increased the cell distribution in S phase, while producing a remarkable induction of autophagy. Finally, the levels of glutathione along with the concentration of hydrogen peroxide and nitrogen oxide were modulated in the treated cells. Herein, we show that red and wine extracts have direct effects on the proliferation, survival, oxidative status, and the induction of autophagy of PC-3 cells. Our data may have important implications for the design of a more effective adjuvant treatment for prostate cancer patients.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28742384     DOI: 10.1080/01635581.2017.1340489

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  2 in total

Review 1.  The Potential Role of Dietary Platelet-Activating Factor Inhibitors in Cancer Prevention and Treatment.

Authors:  Ronan Lordan; Alexandros Tsoupras; Ioannis Zabetakis
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

Review 2.  The impact of moderate wine consumption on the risk of developing prostate cancer.

Authors:  Mihai Dorin Vartolomei; Shoji Kimura; Matteo Ferro; Beat Foerster; Mohammad Abufaraj; Alberto Briganti; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  Clin Epidemiol       Date:  2018-04-17       Impact factor: 4.790

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.